Urologix is a Minneapolis-based company that develops, manufactures and markets medical devices for the treatment of urological disorders. Its technologies serve as treatment options for a wide range of patients with benign prostatic hyperplasia. Its patented Cooled ThermoTherapy is used to treat men with BPH. Cooled ThermoTherapy systems deliver precise microwave energy to heat and destroy enlarged prostate tissue while unique cooling mechanisms protect surrounding healthy, sensitive tissue. Urologix was founded in 1991 and trades on the NASDAQ under the symbol UGLX.